stroke: Acute stroke, endovascular treatment has many benefits

Stroke is the third leading cause of death and the most important cause of disability in the world

The treatment of acute ischemic stroke aims at early recanalization of blood vessels to restore blood flow

Although endovascular treatment is an expensive treatment, compared with standard treatment, it can improve long-term survival and quality of life, reduce the need for rehabilitation and nursing homes after discharge, so it is likely to be cost-effective

They conducted a two-year economic evaluation from a social perspective

The calculation method of the incremental cost-benefit ratio is: the additional cost for each additional functionally independent patient (modified Rankin scale 0-2 points) and the additional cost for each additional quality-adjusted life year

They found that the average cost per patient in the intervention group was US$126,494, compared to US$143,331 in the control group (the average difference was US$-16,839 [95% CI, US$38,113 to US$5456])

Compared with patients in the control group, more patients in the intervention group achieved functional independence, 37.

Endovascular treatment dominates the standard treatment.

The important significance of this study lies in the discovery: for patients with acute ischemic stroke, adding endovascular treatment to conventional treatment is clinically effective, and it can save costs compared with simple conventional treatment